The Ensign Group (NASDAQ:ENSG) Director Sells $67,055.52 in Stock

The Ensign Group, Inc. (NASDAQ:ENSG) Director John Agwunobi sold 392 shares of the firm’s stock in a transaction dated Monday, July 20th. The stock was sold at an average price of $171.06, for a total value of $67,055.52. Following the sale, the director directly owned 9,503 shares in the company, valued at approximately $1,625,583.18. This represents a 3.96% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

The Ensign Group Trading Down 1.7%

NASDAQ:ENSG opened at $178.83 on Friday. The company has a debt-to-equity ratio of 0.06, a current ratio of 1.21 and a quick ratio of 1.56. The business’s 50-day simple moving average is $165.69 and its 200-day simple moving average is $184.00. The Ensign Group, Inc. has a fifty-two week low of $141.58 and a fifty-two week high of $218.00. The stock has a market capitalization of $10.42 billion, a PE ratio of 28.03, a price-to-earnings-growth ratio of 1.78 and a beta of 0.69.

The Ensign Group (NASDAQ:ENSG) last posted its earnings results on Monday, July 27th. The company reported $1.92 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.80 by $0.12. The business had revenue of $1.44 billion during the quarter, compared to analysts’ expectations of $1.44 billion. The Ensign Group had a return on equity of 16.75% and a net margin of 6.90%.The Ensign Group’s revenue for the quarter was up 16.7% compared to the same quarter last year. During the same period in the prior year, the business earned $1.59 EPS. The Ensign Group has set its FY 2026 guidance at 7.750-7.850 EPS. Sell-side analysts expect that The Ensign Group, Inc. will post 6.82 earnings per share for the current fiscal year.

The Ensign Group Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, July 31st. Stockholders of record on Tuesday, June 30th will be given a dividend of $0.065 per share. The ex-dividend date of this dividend is Tuesday, June 30th. This represents a $0.26 annualized dividend and a dividend yield of 0.1%. The Ensign Group’s dividend payout ratio is currently 4.08%.

Analysts Set New Price Targets

Several research firms recently commented on ENSG. Wall Street Zen cut shares of The Ensign Group from a “buy” rating to a “hold” rating in a research report on Saturday, July 25th. Zacks Research cut The Ensign Group from a “strong-buy” rating to a “hold” rating in a report on Monday, April 6th. Royal Bank Of Canada reissued an “outperform” rating and issued a $228.00 price target on shares of The Ensign Group in a research note on Tuesday. Weiss Ratings lowered The Ensign Group from a “buy (b)” rating to a “buy (b-)” rating in a report on Tuesday, June 16th. Finally, Truist Financial upped their price objective on The Ensign Group from $202.00 to $207.00 and gave the stock a “hold” rating in a research report on Thursday. Four investment analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average target price of $216.25.

The Ensign Group News Summary

Here are the key news stories impacting The Ensign Group this week:

• Positive Sentiment: Q2 results exceeded expectations: Ensign reported adjusted EPS of $1.92, above the $1.80 consensus, while revenue reached approximately $1.44 billion and increased 16.7% year over year. Growth was supported by higher occupancy, patient days and contributions from acquired facilities. ENSG Q2 Earnings Beat Estimates
• Positive Sentiment: 2026 outlook was raised: Management increased full-year adjusted EPS guidance to $7.75–$7.85, signaling continued confidence in occupancy trends, facility growth and operating performance.
• Positive Sentiment: Truist raised its price target: Truist Financial lifted its target from $202 to $207, although it retained a “hold” rating. The revision provides valuation support but reflects a more cautious view than a bullish upgrade. Truist raises ENSG price target
• Neutral Sentiment: Insider transaction: Director John Agwunobi sold 392 shares worth about $67,056 under a pre-arranged Rule 10b5-1 plan. The relatively small, planned sale reduces its value as a bearish signal.
• Negative Sentiment: Legal overhang intensified: Rosen Law Firm announced an investigation into allegations that Ensign may have issued materially misleading business information. The announcement follows similar investigations by Kaplan Fox and Bleichmar Fonti & Auld, creating potential litigation, regulatory and reputational risks. The allegations have not been proven. Rosen Law Firm Ensign investigation

Institutional Trading of The Ensign Group

A number of institutional investors have recently made changes to their positions in the business. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC grew its position in The Ensign Group by 9.9% in the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 161,946 shares of the company’s stock valued at $20,956,000 after purchasing an additional 14,590 shares in the last quarter. Geneos Wealth Management Inc. lifted its position in The Ensign Group by 150.3% during the 1st quarter. Geneos Wealth Management Inc. now owns 383 shares of the company’s stock worth $50,000 after buying an additional 230 shares in the last quarter. EverSource Wealth Advisors LLC lifted its position in The Ensign Group by 65.9% during the 2nd quarter. EverSource Wealth Advisors LLC now owns 536 shares of the company’s stock worth $83,000 after buying an additional 213 shares in the last quarter. Amundi boosted its stake in shares of The Ensign Group by 480,216.7% during the 2nd quarter. Amundi now owns 57,638 shares of the company’s stock worth $8,583,000 after buying an additional 57,626 shares during the last quarter. Finally, Brown Advisory Inc. boosted its stake in shares of The Ensign Group by 26.1% during the 2nd quarter. Brown Advisory Inc. now owns 2,037 shares of the company’s stock worth $314,000 after buying an additional 421 shares during the last quarter. Institutional investors own 96.12% of the company’s stock.

The Ensign Group Company Profile

The Ensign Group, Inc is a diversified provider of post-acute healthcare services in the United States, operating a network of skilled nursing, assisted living, independent living, home health and hospice care centers. The company’s model emphasizes integrated care by employing multidisciplinary teams—including nursing staff, therapists and physicians—to deliver personalized rehabilitation and long-term care services for seniors and other patients recovering from injury, illness or surgery.

Through its owned and managed centers, The Ensign Group offers a broad spectrum of rehabilitation services such as physical, occupational and speech therapy.